Sun Pharmaceuticals Industries Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sun Pharmaceuticals Industries Ltd with three other
pharmaceutical manufacturers in Asia:
Sumitomo Dainippon Pharma Co Ltd
sales of 466.84 billion Japanese Yen [US$4.22 billion]
of which 52%
was Pharmaceutical business in Northern Amer),
Moriroku Holdings Co Ltd
(182.18 billion Japanese Yen [US$1.65 billion]
of which 63%
was Resin processing products business), and
Hisamitsu Pharmaceutical Co Inc
based in Japan
(147.87 billion Japanese Yen [US$1.34 billion]
of which 100%
Sun Pharmaceuticals Industries Ltd reported sales of 264.16 billion Indian Rupees (US$3.75 billion)
March of 2018.
decrease of 15.6%
versus 2017, when the company's sales were 313.08 billion Indian Rupees.